Obinutuzumab in Combination with Chemotherapy for the First-Line Treatment of Patients with Advanced Follicular Lymphoma: An Evidence Review Group Evaluation of the NICE Single Technology Appraisal

The National Institute for Health and Care Excellence (NICE), as part of the institute’s single technology appraisal (STA) process, invited the company that makes obinutuzumab (Roche Products Limited) to submit evidence of the clinical and cost effectiveness of the drug in combination with chemother...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pharmacoeconomics
Hauptverfasser: Thielen, Frederick W., Büyükkaramikli, Nasuh C., Riemsma, Rob, Fayter, Debra, Armstrong, Nigel, Wei, Ching-Yun, Huertas Carrera, Vanesa, Misso, Kate, Worthy, Gill, Kleijnen, Jos, Corro Ramos, Isaac
Format: Artigo
Sprache:Inglês
Veröffentlicht: Springer International Publishing 2018
Schlagworte:
Review Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6598743/
https://ncbi.nlm.nih.gov/pubmed/30547368
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40273-018-0740-4
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge